NEUMORA THERAPEUTICS, INC. Employee Count
The employee counts NEUMORA THERAPEUTICS, INC. states in its annual reports on SEC EDGAR, each as filed.
- 2024-12-31: Employees (as filed) 110; Filing 2025-03-03.
- 2023-12-31: Employees (as filed) 124; Filing 2024-03-07; Lease expense per employee $2,419.35.
- Available history
- 2023-12-31 to 2024-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2024-12-31 | 110 full-time | 2025-03-03 | |
| 2023-12-31 | 124 full-time | 2024-03-07 | $2,419.35 short-term |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |